Kura Oncology, Inc. (KURA)
NASDAQ: KURA · Real-Time Price · USD
10.16
+0.22 (2.21%)
At close: Nov 6, 2025, 4:00 PM EST
10.07
-0.09 (-0.90%)
Pre-market: Nov 7, 2025, 8:34 AM EST
Kura Oncology Analyst Ratings
Total Analysts
13
Consensus Rating
Strong Buy
Price Target
$25.00
Upside
+146.06%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JMP Securities | JMP Securities | Buy Reiterates $24 | Buy | Reiterates | $24 | +136.22% | Oct 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +293.70% | Oct 20, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +293.70% | Sep 30, 2025 |
| Guggenheim | Guggenheim | Hold Initiates n/a | Hold | Initiates | n/a | n/a | Sep 4, 2025 |
| JMP Securities | JMP Securities | Buy Maintains $28 → $24 | Buy | Maintains | $28 → $24 | +136.22% | Aug 11, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 26, 2025 |
| Wedbush | Wedbush | Buy Reiterates $36 | Buy | Reiterates | $36 | +254.33% | Jun 20, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $28 | Buy | Reiterates | $28 | +175.59% | Jun 4, 2025 |
| Mizuho | Mizuho | Buy Maintains $32 → $30 | Buy | Maintains | $32 → $30 | +195.28% | May 19, 2025 |
| Barclays | Barclays | Buy Maintains $32 → $11 | Buy | Maintains | $32 → $11 | +8.27% | May 2, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $28 | Buy | Reiterates | $28 | +175.59% | Apr 29, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +293.70% | Apr 28, 2025 |
| UBS | UBS | Strong Buy Maintains $27 → $14 | Strong Buy | Maintains | $27 → $14 | +37.80% | Mar 6, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $40 | Strong Buy | Reiterates | $40 | +293.70% | Feb 27, 2025 |
| JMP Securities | JMP Securities | Buy Reiterates $28 | Buy | Reiterates | $28 | +175.59% | Feb 6, 2025 |
| Wedbush | Wedbush | Buy Maintains $34 → $36 | Buy | Maintains | $34 → $36 | +254.33% | Feb 6, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.